Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.13 AUD | +18.18% |
|
-3.70% | -31.58% |
06-04 | Nuchev Appoints Interim CFO | MT |
05-20 | Nuchev Agrees to Acquire bWellness for AU$7 million; Launches AU$5.1 Million Entitlement Offer | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.73 for the current period. Therefore, the company is undervalued.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- The group shows a rather high level of debt in proportion to its EBITDA.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-31.58% | 7.76M | - | ||
-3.63% | 22.52B | B+ | ||
-37.33% | 6.64B | A- | ||
-12.29% | 6.27B | B- | ||
+5.44% | 6.17B | A | ||
-0.22% | 5.44B | B | ||
-2.37% | 5.42B | B+ | ||
+26.56% | 5.24B | C+ | ||
-11.94% | 4.37B | B- | ||
+3.39% | 3.83B | - | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- NUC Stock
- Ratings Nuchev Limited